391 related articles for article (PubMed ID: 23073833)
1. Overcoming barriers to the clinical utilization of iPSCs: reprogramming efficiency, safety and quality.
Cao S; Loh K; Pei Y; Zhang W; Han J
Protein Cell; 2012 Nov; 3(11):834-45. PubMed ID: 23073833
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
[TBL] [Abstract][Full Text] [Related]
3. Experimental approaches for the generation of induced pluripotent stem cells.
Sommer CA; Mostoslavsky G
Stem Cell Res Ther; 2010 Aug; 1(3):26. PubMed ID: 20699015
[TBL] [Abstract][Full Text] [Related]
4. Induced pluripotent stem cells reprogramming: Epigenetics and applications in the regenerative medicine.
Gomes KM; Costa IC; Santos JF; Dourado PM; Forni MF; Ferreira JC
Rev Assoc Med Bras (1992); 2017 Feb; 63(2):180-189. PubMed ID: 28355380
[TBL] [Abstract][Full Text] [Related]
5. Generation of Human iPSCs by Protein Reprogramming and Stimulation of TLR3 Signaling.
Liu C; Ameen M; Himmati S; Thomas D; Sayed N
Methods Mol Biol; 2021; 2239():153-162. PubMed ID: 33226618
[TBL] [Abstract][Full Text] [Related]
6. Reliable generation of induced pluripotent stem cells from human lymphoblastoid cell lines.
Barrett R; Ornelas L; Yeager N; Mandefro B; Sahabian A; Lenaeus L; Targan SR; Svendsen CN; Sareen D
Stem Cells Transl Med; 2014 Dec; 3(12):1429-34. PubMed ID: 25298370
[TBL] [Abstract][Full Text] [Related]
7. Integration-free reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) without viral vectors, recombinant DNA, and genetic modification.
Heng BC; Fussenegger M
Methods Mol Biol; 2014; 1151():75-94. PubMed ID: 24838880
[TBL] [Abstract][Full Text] [Related]
8. Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system.
Drozd AM; Walczak MP; Piaskowski S; Stoczynska-Fidelus E; Rieske P; Grzela DP
Stem Cell Res Ther; 2015 Jun; 6(1):122. PubMed ID: 26088261
[TBL] [Abstract][Full Text] [Related]
9. Induced pluripotency and direct reprogramming: a new window for treatment of neurodegenerative diseases.
Li R; Bai Y; Liu T; Wang X; Wu Q
Protein Cell; 2013 Jun; 4(6):415-24. PubMed ID: 23686735
[TBL] [Abstract][Full Text] [Related]
10. Choices for Induction of Pluripotency: Recent Developments in Human Induced Pluripotent Stem Cell Reprogramming Strategies.
Brouwer M; Zhou H; Nadif Kasri N
Stem Cell Rev Rep; 2016 Feb; 12(1):54-72. PubMed ID: 26424535
[TBL] [Abstract][Full Text] [Related]
11. Present and future challenges of induced pluripotent stem cells.
Ohnuki M; Takahashi K
Philos Trans R Soc Lond B Biol Sci; 2015 Oct; 370(1680):20140367. PubMed ID: 26416678
[TBL] [Abstract][Full Text] [Related]
12. Generation of Induced Pluripotent Stem Cells with Substitutes for Yamanaka's Four Transcription Factors.
Xiao X; Li N; Zhang D; Yang B; Guo H; Li Y
Cell Reprogram; 2016 Oct; 18(5):281-297. PubMed ID: 27696909
[TBL] [Abstract][Full Text] [Related]
13. Progress in the reprogramming of somatic cells.
Ma T; Xie M; Laurent T; Ding S
Circ Res; 2013 Feb; 112(3):562-74. PubMed ID: 23371904
[TBL] [Abstract][Full Text] [Related]
14. Induced pluripotent stem cells: fundamentals and applications of the reprogramming process and its ramifications on regenerative medicine.
Walia B; Satija N; Tripathi RP; Gangenahalli GU
Stem Cell Rev Rep; 2012 Mar; 8(1):100-15. PubMed ID: 21671061
[TBL] [Abstract][Full Text] [Related]
15. Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications.
Yoshihara M; Hayashizaki Y; Murakawa Y
Stem Cell Rev Rep; 2017 Feb; 13(1):7-16. PubMed ID: 27592701
[TBL] [Abstract][Full Text] [Related]
16. An Insight into Reprogramming Barriers to iPSC Generation.
Haridhasapavalan KK; Raina K; Dey C; Adhikari P; Thummer RP
Stem Cell Rev Rep; 2020 Feb; 16(1):56-81. PubMed ID: 31758374
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of miRNA-212/132 improves the reprogramming of fibroblasts into induced pluripotent stem cells by de-repressing important epigenetic remodelling factors.
Pfaff N; Liebhaber S; Möbus S; Beh-Pajooh A; Fiedler J; Pfanne A; Schambach A; Thum T; Cantz T; Moritz T
Stem Cell Res; 2017 Apr; 20():70-75. PubMed ID: 28314201
[TBL] [Abstract][Full Text] [Related]
18. Reprogramming of Keratinocytes as Donor or Target Cells Holds Great Promise for Cell Therapy and Regenerative Medicine.
Zhang Y; Hu W; Ma K; Zhang C; Fu X
Stem Cell Rev Rep; 2019 Oct; 15(5):680-689. PubMed ID: 31197578
[TBL] [Abstract][Full Text] [Related]
19. Liver biopsy derived induced pluripotent stem cells provide unlimited supply for the generation of hepatocyte-like cells.
Calabrese D; Roma G; Bergling S; Carbone W; Mele V; Nuciforo S; Fofana I; Campana B; Szkolnicka D; Hay DC; Tchorz J; Bouwmeester T; Wieland S; Heim MH
PLoS One; 2019; 14(8):e0221762. PubMed ID: 31465481
[TBL] [Abstract][Full Text] [Related]
20. A practical and efficient cellular substrate for the generation of induced pluripotent stem cells from adults: blood-derived endothelial progenitor cells.
Geti I; Ormiston ML; Rouhani F; Toshner M; Movassagh M; Nichols J; Mansfield W; Southwood M; Bradley A; Rana AA; Vallier L; Morrell NW
Stem Cells Transl Med; 2012 Dec; 1(12):855-65. PubMed ID: 23283547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
